This suggests that identification of estradiol-regulated genes [32] or tamoxifen-regulated genes [33]in vitro might be a good approach to selecting prognostic or predictive molecular markers of ER-positive breast cancer [32-34]. Here, ESR1 is linked to breast carcinoma.